Navigation Links
Web Page to Warn Against Online Purchase of Isotretinoin

On Wednesday, the FDA launched a special Web page. This web page is aimed at discouraging consumers from purchasing the acne drug isotretinoin, sold by Roche// under the brand name Accutane, on the Internet.

The drug claims to cure severe acne that is not controlled by other treatment forms. FDA warns that if used improperly, the drug causes birth defects and severe mental health problems.

The FDA warning page appears in online search results for Accutane (isotretinoin) or its other generic versions(Amnesteem, Claravis, or Sotret) FDA advises that this drug be taken only under the direction of a physician or a pharmacist.

Isotretinoin manufacturers have already issued safeguards to reduce the risks of the drug, like the iPLEDGE risk management program. They warn women using isotretinoin to stop using the drug in case of pregnancy and pregnant women not to use isotretinoin.

Research studies have revealed that isotretinoin causes severe side effects in expectant mothers, such as birth defects and fetal death, and also might cause depression and suicide.

FDA data released in 2004 showed that these measures had little effect on the number of pregnant women taking the drug.

The FDA began to register physicians, prescription drug wholesalers, pharmacists and women into iPledge, since Dec. 30, 2005, which asks women to submit two negative pregnancy tests in order to receive a prescription for isotretinoin.

Women have to undergo a pregnancy test every month and must accept to use two different forms of birth control at the time of treatment with isotretinoin and for one month after treatment has ended, according to FDA.

Women also have to sign a text to acknowledge that isotretinoin can amplify risk for birth defects, depression and suicidal thoughts. About 165,000 people have registered with iPledge, which FDA administers jointly with companies that sell the drug.

The Web page was launched as FDA officials' felt that some are purchasing the drug on line to avoid involvement in iPledge.

The Web page has links to other info about the drug, including a link to iPledge. The Web page gets connected when people search for Accutane, or any of its three generic versions -- Amnesteem from Mylan Laboratories, Claravis from Barr Pharmaceuticals and Sotret from Ranbaxy Laboratories.
PRI
'"/>




Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Diabetics Need to Guard Against Nail Fungus
3. New Weapon Against Germs
4. Estrogen Found To Protect the Colon Against Cancer
5. Diet Found To Offer Protection Against Leukemia
6. Olive Oil Found To Offer A Protective Effect Against Breast Cancer
7. WHO Issues Caution Against Bird Flu Epidemic
8. New Supplement Found To Be Effective Against Sunburn
9. Intense Fight Against Polio In India Gets Results
10. Prime Minister Manmohan Against Incentive-Based Population Control
11. Scientists Warn Against Food Borne Illnesses
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: